Intractable Pelvic Cancer Pain
Conditions
Brief summary
fluoroscopic group & includes 30 patients where SHPB will be done Fluoroscopic-guided (the posterior oblique trajectory technique.the double modality group & includes 30 patients where SHPB will be done using our described new technique of performing the modified Mishra technique by injecting 3-5 ml of contrast media (lohexol=omnipaque) after getting the target position.
Interventions
PROCEDUREfluroscopic guided block
SHPB will be done Fluoroscopic-guided (the posterior oblique trajectory technique.
PROCEDUREdouble modality (ultrasound and fluroscopic) guided block
SHPB will be done using our described new technique of performing the modified Mishra technique by injecting 3-5 ml of contrast media (lohexol=omnipaque) after getting the target position. Then C-arm pictures will be checked (both P-A & dead lateral)
Sponsors
Assiut University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* Age \> 18 years. * Intractable pelvic cancer pain (VAS \> 40 mm) * Pain is refractory to pharmacotherapy (both opioids and adjuvant therapy) or opioids' side effects are not tolerated.
Exclusion criteria
* Local or systemic sepsis. * Uncorrectable coagulopathy. * Neuropsychiatric illness. * History of drug abuse. * Pregnant or lactating patients. * Distorted local anatomy. * Patients who are known to be allergic to the used medications. * Cardiovascular or respiratory instability.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| pain relief will be assessed by VAS | 12 weeks | pain relief will be assessed by VAS (visual Analogue score) which is 100 mscale with left (0) end means no pain & right (10) end means the worst possible pain |
Countries
Egypt
Outcome results
None listed